Target intelligence / Profile preview

Dynamin-binding protein (DNMBP)

Target
DNMBP
Molecular classification
Guanine nucleotide exchange factor (GEF), Scaffold protein, Rho GTPase regulator
01

Overview

Dynamin-binding protein (DNMBP), also known as ARHGEF36, KIAA1010, and Tuba, is a guanine nucleotide exchange factor (GEF) that primarily activates CDC42, a member of the Rho GTPase family[1][2][4]. DNMBP serves as a scaffold protein, facilitating interactions between dynamin and actin regulatory proteins to organize the actin and microtubule cytoskeleton essential for cell structure and signaling[2][7]. It is involved in regulating the structure of apical junctions in epithelial cells through F-actin organization, spindle orientation during lumenogenesis, and possibly ciliogenesis and membrane trafficking[1][2][5]. DNMBP gene polymorphisms have been linked to certain cataract types and may be associated with susceptibility to Alzheimer’s disease in specific populations, though with conflicting evidence[2]. Alternative splicing results in multiple transcript variants for this protein[2]. DNMBP forms part of cellular pathways involving Rho GTPase signaling, essential for cytoskeletal dynamics and cell junction configuration[2][4]. It is considered a molecular target due to its role as a GEF in signaling pathways relevant to disease and cell biology[2][4].

Other names
KIAA1010TubaARHGEF36Scaffold protein TubaCTRCT48ENSG00000107554
02

Biological functions

Regulation of actin and microtubule cytoskeletonGuanine nucleotide exchange for CDC42 (GEF activity)Maintenance of apical junction structure in epithelial cellsSpindle orientation and lumenogenesis in epithelial cystsCiliogenesis (by similarity)Membrane trafficking (by similarity)
03

Disease associations

Cataract (noted types include Cataract 44 and Cataract 48)Potential role in Alzheimer’s disease (conflicting population studies)

Beyond the preview

Go deeper on Dynamin-binding protein (DNMBP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dynamin-binding protein (DNMBP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call